|
US10266585B2
(en)
*
|
2009-08-28 |
2019-04-23 |
The Board Of Regents Of The Univerity Of Texas System |
Methods of treating brain injury
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
ES2548686T3
(es)
*
|
2010-10-07 |
2015-10-20 |
Ac Immune S.A. |
Anticuerpos que reconocen fosfo-Tau
|
|
BR112013008765B8
(pt)
|
2010-10-11 |
2023-05-02 |
Biogen Idec Int Neuroscience Gmbh |
Anticorpos monoclonais anti-tau humano isolados ou um fragmento de ligação à tau dos mesmos, métodos de preparação dos mesmos, polinucleotídeo ou polinucleotídeos, vetor ou vetores, composição, método in vitro de diagnóstico ou monitoramento da progressão de uma tauopatia neurodegenerativa em um indivíduo humano, método in vitro para diagnosticar uma tauopatia neurodegenerativa em um indivíduo humano, e kit útil para o diagnóstico de uma tauopatia neurodegenerativa
|
|
US8703137B2
(en)
|
2011-01-31 |
2014-04-22 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
US10314594B2
(en)
|
2012-12-14 |
2019-06-11 |
Corquest Medical, Inc. |
Assembly and method for left atrial appendage occlusion
|
|
US10813630B2
(en)
|
2011-08-09 |
2020-10-27 |
Corquest Medical, Inc. |
Closure system for atrial wall
|
|
US10307167B2
(en)
|
2012-12-14 |
2019-06-04 |
Corquest Medical, Inc. |
Assembly and method for left atrial appendage occlusion
|
|
ES2655051T3
(es)
|
2011-08-26 |
2018-02-16 |
Wisconsin Alumni Research Foundation |
Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
|
|
RU2639537C2
(ru)
*
|
2011-10-07 |
2017-12-21 |
Ац Иммуне С.А. |
Фосфоспецифичные антитела, распознающие тау
|
|
US9371376B2
(en)
|
2011-12-20 |
2016-06-21 |
Janssen Biotech, Inc. |
Anti-PHF-tau antibodies and their uses
|
|
JP6293731B2
(ja)
*
|
2012-04-05 |
2018-03-14 |
エーシー イミューン エス．エー． |
ヒト化タウ抗体
|
|
HK1209768A1
(en)
|
2012-07-03 |
2016-04-08 |
Washington University |
Antibodies to tau
|
|
WO2014016737A1
(en)
*
|
2012-07-24 |
2014-01-30 |
Pfizer Inc. |
Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof
|
|
PE20150646A1
(es)
|
2012-08-16 |
2015-05-21 |
Ipierian Inc |
Metodos de tratamiento de una tauopatia
|
|
US12024568B2
(en)
|
2012-09-13 |
2024-07-02 |
Cornell University |
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
|
|
US20140142689A1
(en)
|
2012-11-21 |
2014-05-22 |
Didier De Canniere |
Device and method of treating heart valve malfunction
|
|
PT2935326T
(pt)
|
2012-12-21 |
2020-09-14 |
Biogen Ma Inc |
Anticorpos anti-tau humanos
|
|
US8980270B2
(en)
|
2013-01-18 |
2015-03-17 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
CN105143258B
(zh)
*
|
2013-03-15 |
2020-06-23 |
Ac免疫有限公司 |
抗Tau抗体和使用方法
|
|
SG11201509982UA
(https=)
|
2013-06-06 |
2016-04-28 |
Igenica Biotherapeutics Inc |
|
|
GB201312226D0
(en)
*
|
2013-07-08 |
2013-08-21 |
Adx Neurosciences |
Improved antibodies
|
|
US9566443B2
(en)
|
2013-11-26 |
2017-02-14 |
Corquest Medical, Inc. |
System for treating heart valve malfunction including mitral regurgitation
|
|
EP3074420A2
(en)
*
|
2013-11-27 |
2016-10-05 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
HRP20200384T1
(hr)
|
2013-12-20 |
2020-06-12 |
F. Hoffmann - La Roche Ag |
Humanizirana anti-tau(ps422) protutijela i načini uporabe
|
|
WO2015122922A1
(en)
*
|
2014-02-14 |
2015-08-20 |
Ipierian, Inc. |
Tau peptides, anti-tau antibodies, and methods of use thereof
|
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
TWI664190B
(zh)
|
2014-06-27 |
2019-07-01 |
美商Ｃ２Ｎ醫療診斷有限責任公司 |
人類化抗－ｔａｕ抗體
|
|
US10830775B2
(en)
|
2014-09-30 |
2020-11-10 |
Washington University |
Tau kinetic measurements
|
|
SI3221349T1
(sl)
*
|
2014-11-19 |
2021-02-26 |
Axon Neuroscience Se |
Humanizirano tau protitelo pri alzheimerjevi bolezni
|
|
US10842626B2
(en)
|
2014-12-09 |
2020-11-24 |
Didier De Canniere |
Intracardiac device to correct mitral regurgitation
|
|
AR103713A1
(es)
|
2015-02-26 |
2017-05-31 |
Lilly Co Eli |
Anticuerpos contra tau y sus usos
|
|
EP4465050A3
(en)
|
2015-06-05 |
2025-06-11 |
Genentech, Inc. |
Anti-tau antibodies and methods of use
|
|
CN107810196B
(zh)
|
2015-06-24 |
2021-11-05 |
豪夫迈·罗氏有限公司 |
人源化的抗-Tau(pS422)抗体和使用方法
|
|
KR102770650B1
(ko)
|
2015-07-06 |
2025-02-19 |
유씨비 바이오파마 에스알엘 |
타우 결합 항체
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
FI3334761T3
(fi)
*
|
2015-08-13 |
2023-08-14 |
Univ New York |
Vasta-ainepohjaisia molekyylejä, jotka ovat selektiivisiä Taun {p}Ser404-epitoopille, ja niiden käyttöjä tauopatian diagnosoinnissa ja hoidossa
|
|
CA3014435C
(en)
|
2016-02-19 |
2023-04-18 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza b virus replication for vaccine development
|
|
PL3484916T3
(pl)
*
|
2016-07-12 |
2021-07-19 |
H. Lundbeck A/S |
Przeciwciała swoiste wobec hiperfosforylowanego białka tau i sposoby ich zastosowania
|
|
EP3496750A2
(en)
|
2016-08-09 |
2019-06-19 |
Eli Lilly and Company |
Combination therapy
|
|
MA48595A
(fr)
*
|
2016-12-07 |
2020-03-18 |
Ac Immune Sa |
Anticorps anti-tau et leurs méthodes d'utilisation
|
|
CN117820467A
(zh)
|
2016-12-07 |
2024-04-05 |
基因泰克公司 |
抗tau抗体和使用方法
|
|
WO2018127519A1
(en)
*
|
2017-01-04 |
2018-07-12 |
H. Lundbeck A/S |
Antibodies specific for hyperphosphorylated tau for the treatment of ocular diseases
|
|
BR112019017021A2
(pt)
|
2017-02-17 |
2020-04-14 |
Denali Therapeutics Inc |
anticorpos anti-tau e métodos de uso dos mesmos
|
|
JP2018139530A
(ja)
*
|
2017-02-27 |
2018-09-13 |
帝人ファーマ株式会社 |
認知症治療又は予防のためのヒト化抗体及びその製造方法、並びにそれを用いた認知症治療剤又は予防剤
|
|
EA039569B1
(ru)
*
|
2017-03-14 |
2022-02-11 |
Х. Лундбекк А/С |
Антитела, специфичные к гиперфосфорилированному тау-белку, и способы их применения
|
|
TWI771389B
(zh)
|
2017-03-16 |
2022-07-21 |
美商健生生物科技公司 |
抗phf-tau抗體及其用途
|
|
WO2018217630A1
(en)
*
|
2017-05-21 |
2018-11-29 |
University Of Tennessee Research Foundation |
Methods and compositions for targeting tissue lesions
|
|
EP3697814A1
(en)
|
2017-10-16 |
2020-08-26 |
Eisai R&D Management Co., Ltd. |
Anti-tau antibodies and uses thereof
|
|
WO2019084310A1
(en)
|
2017-10-25 |
2019-05-02 |
Yoshihiro Kawaoka |
HAS RECOMBINANT INFLUENZA VIRUSES STABILIZED FOR EGG REPLICATION
|
|
US11896680B2
(en)
*
|
2017-11-28 |
2024-02-13 |
Mie University |
Detection method
|
|
CA3093200A1
(en)
|
2018-03-05 |
2019-09-12 |
Janssen Pharmaceutica Nv |
Anti-phf-tau antibodies and uses thereof
|
|
CA3107788A1
(en)
|
2018-07-31 |
2020-02-06 |
Eli Lilly And Company |
Combination of anti-tau antibody and oga inhibitor for treatment of diseases characterized by aberrant tau aggregation
|
|
US12343390B2
(en)
|
2018-08-07 |
2025-07-01 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant biologically contained filovirus vaccine
|
|
JP7655849B2
(ja)
|
2018-08-20 |
2025-04-02 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ヘマグルチニン（ｈａ）タンパク質内の非ドミナントエピトープに対する免疫応答を誘起するためのベクター
|
|
WO2020073917A1
(en)
*
|
2018-10-09 |
2020-04-16 |
Single Cell Technology, Inc. |
Anti-bcma antibodies
|
|
US20210347869A1
(en)
*
|
2018-10-17 |
2021-11-11 |
The University Of Queensland |
Methods and compositions for treating tauopathies
|
|
CA3118692A1
(en)
|
2018-11-06 |
2020-05-14 |
Alsatech, Inc. |
Cell-based gene therapy for neurodegenerative diseases
|
|
CN113543808A
(zh)
*
|
2019-01-04 |
2021-10-22 |
特瑞奥制药公司 |
多特异性蛋白质分子及其用途
|
|
WO2020163804A1
(en)
|
2019-02-08 |
2020-08-13 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
|
WO2020201828A1
(en)
|
2019-04-05 |
2020-10-08 |
Tauc3 Biologics Limited |
Anti-tauc3 antibodies and uses thereof
|
|
US20220162301A1
(en)
*
|
2019-04-12 |
2022-05-26 |
PhanesTherapeutics, Inc. |
Humanized anti-folate receptor 1 chimeric antigen receptors and uses thereof
|
|
US11390649B2
(en)
|
2019-05-01 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication for vaccine development
|
|
CN110028583B
(zh)
*
|
2019-05-07 |
2020-09-11 |
温州医科大学 |
抗Tau抗体及其在治疗阿尔茨海默病、创伤性脑损伤中的应用
|
|
US11807872B2
(en)
|
2019-08-27 |
2023-11-07 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized HA for replication in eggs
|
|
CN112752251B
(zh)
*
|
2019-10-29 |
2022-05-06 |
中国移动通信有限公司研究院 |
一种ue标识符的分配方法、装置和计算机可读存储介质
|
|
WO2021150874A1
(en)
|
2020-01-24 |
2021-07-29 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized na
|
|
WO2021157634A1
(ja)
*
|
2020-02-05 |
2021-08-12 |
大日本住友製薬株式会社 |
タウオパチーおよび認知症関連疾患の判定薬および判定方法
|
|
US12290562B2
(en)
|
2020-03-25 |
2025-05-06 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
CA3183835A1
(en)
|
2020-06-25 |
2021-12-30 |
Jeanne E. Baker |
High affinity antibodies targeting tau phosphorylated at serine 413
|
|
EP4263599A1
(en)
*
|
2020-12-16 |
2023-10-25 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
|
EP4014997A1
(en)
|
2020-12-16 |
2022-06-22 |
Consejo Superior de Investigaciones Científicas (CSIC) |
Stard1 inhibitors for the treatment of lysosomal disorders
|
|
IL305666A
(en)
*
|
2021-03-18 |
2023-11-01 |
Seagen Inc |
Anti-ALPP/ALPPL2 antibodies and antibody-drug conjugates
|
|
CL2021001380A1
(es)
|
2021-05-26 |
2022-01-14 |
Corporacion Centro Int De Biomedicina Icc |
Generación de un nuevo anticuerpo monoclonal sitio específico para la proteína tau y su uso como herramienta en biomarcadores específicos para la detección temprana de enfermedades neurodegenerativas y patologías involucradas con la proteína tau como alzheimer y otras demencias.
|
|
US20250034559A1
(en)
|
2021-11-17 |
2025-01-30 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
CA3266790A1
(en)
|
2022-09-15 |
2024-03-21 |
Voyager Therapeutics, Inc. |
TAU PROTEIN BINDING COMPOUNDS
|
|
WO2024163923A2
(en)
*
|
2023-02-02 |
2024-08-08 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Phosphomimetic mutants, phosphospecific antibodies, and uses thereof
|
|
WO2025122634A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of tau-related disorders
|
|
WO2025128975A1
(en)
*
|
2023-12-14 |
2025-06-19 |
Immunitas Therapeutics, Inc. |
Cd161 binding proteins and related methods
|
|
WO2025134068A1
(en)
|
2023-12-22 |
2025-06-26 |
Ac Immune Sa |
Antibody drug conjugates targeting proteinopathies, and uses thereof
|